Cohesive inelastic high compression bandage. Short stretch bandage
Type of wound product is suitable for
Venous leg ulceration
Management of chronic oedema
Duration dressing remains on wound before changing
Daily to 7 days
Frequency of dressing change
Dependant on exudate levels if wound present or oedema management.
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Not recommended on those patients with an ABPI lower than 0.8. Caution in diabetic patients
Caution when cardiac overload or renal failure present or suspected.
Rationale for inclusion in formulary
Only cohesive short stretch bandage. Nurses competent in its usage.
100 % cotton short stretch compression bandage
Type of wound product is suitable for Venous leg ulceration Varicosis Management of chronic oedema Management of primary and secondary lymphoedema Deep venous thrombosis Thrombophlebitis
Duration dressing remains on wound before changing 1 to 7 days
Frequency of dressing change Dependant on exudate levels if wound present or oedema management.
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.) Advanced Peripheral arterial occlusive disease Decompensated cardiac insufficiency Septic phlebitis Phlegmasia coerula doleris
Rationale for inclusion in formulary Cotton short stretch bandage. Used by lymphoedema nurse specialists
Sub-compression wadding bandage
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Prescribing in children
The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.
The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.
Medicines suitable for routine use within primary care. Initiation and maintenance of prescribing by Specialists, GPs and other qualified clinicians.
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry.
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry.
Medicines for initiation and maintenance prescribing by Specialists only.
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use.
Positive NICE TA and/or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information.
The term 'Specialist' refers to Consultants, General Practitioners and Independant Prescribers with a Specialist Interest.